ArticleCancer immunology, immunotherapy : CII2014

Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.

Francesca Pretto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.